Alterations in the Plasma Metabolome Associated With Maternal Smoking During the First Trimester and Foetal Growth
Basic & Clinical Pharmacology & Toxicology · 2025
DOI: 10.1111/bcpt.70037 ↗At a glance
Journal article in Basic & Clinical Pharmacology & Toxicology, 2025. Written by Wadzanai Masvosva and 7 co-authors. Institution: School of Pharmacy, University of Eastern Finland, Kuopio, Finland. Major MEDLINE topics: Pregnancy Trimester, First, Metabolome, Fetal Development, Smoking. Cited 5 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Finnish Ministry of Social Affairs and Health, Finnish Foundation for Alcohol Studies.
Abstract (original language)
Tobacco smoking during pregnancy has been associated with an increased risk of adverse outcomes like low birth weight. This study determined changes in the circulating metabolome linked to maternal smoking in the first trimester and correlated these changes to the growth of the foetus. The circulating metabolome was examined from first trimester plasma samples by non‐targeted (global) liquid chromatography mass spectrometry‐based metabolite profiling of 227 pregnant women (99 smokers and 117 non‐smokers) from the Kuopio Birth Cohort Study. Tobacco smoking was self‐reported through a questionnaire and verified with cotinine measurements from plasma samples. In summary, 64 significant differences were observed between the groups after correction for multiple testing e.g. in metabolites indicating endocrine disruption (e.g. dehydroepiandrosterone sulphate [DHEA‐S], VIP = 2.70, d = 0.68, p < 0.0001), metabolites associated with oxidative stress (e.g. bilirubin, VIP = 2.00, d = 0.50, p < 0.0001) and lipid metabolism (e.g. LysoPC 16:1, VIP = 2.07, d = 0.51, p < 0.0001). Some of these metabolites, e.g. DHEA‐S and bilirubin, correlated with low birth weight, and some, e.g. LysoPC 16:1, correlated with small head circumference at birth. In conclusion, maternal smoking during the first trimester of pregnancy was associated with an altered metabolite profile linked to endocrine disruption and increased oxidative stress.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
- Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
- Institute of Clinical Medicine, School of Medicine, University of Eastern Finland, Kuopio, Finland.
- Department of Obstetrics and Gynecology, Kuopio University Hospital, Kuopio, Finland.
ORCID profiles: Wadzanai Masvosva, Taija Voutilainen, Marko Lehtonen, Retu Haikonen, Seppo Auriola, Leea Keski-Nisula, Jaana Rysä, Olli Kärkkäinen
Funding
- Finnish Ministry of Social Affairs and Health
- Finnish Foundation for Alcohol Studies
Cite
APA
Masvosva, W., Voutilainen, T., Lehtonen, M., Haikonen, R., Auriola, S., Keski-Nisula, L., Rysä, J., & Kärkkäinen, O. (2025). Alterations in the Plasma Metabolome Associated With Maternal Smoking During the First Trimester and Foetal Growth. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70037
Vancouver
Masvosva W, Voutilainen T, Lehtonen M, Haikonen R, Auriola S, Keski-Nisula L, et al. Alterations in the Plasma Metabolome Associated With Maternal Smoking During the First Trimester and Foetal Growth. Basic & Clinical Pharmacology & Toxicology. 2025. doi:10.1111/bcpt.70037
BibTeX
@article{Masvosva2025,
author = {Masvosva, Wadzanai and Voutilainen, Taija and Lehtonen, Marko and Haikonen, Retu and Auriola, Seppo and Keski-Nisula, Leea and Rysä, Jaana and Kärkkäinen, Olli},
title = {Alterations in the Plasma Metabolome Associated With Maternal Smoking During the First Trimester and Foetal Growth},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2025},
doi = {10.1111/bcpt.70037}
}
EUVIMED